Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose

Emergency Medicine Journal

Volumn 24, Issue 8, 2007, Pages 580-581

  Hassan, Ziauddin ^a   Wright, John ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLIPIZIDE; GLUCOSE; IMMUNOREACTIVE INSULIN; OCTREOTIDE; SULFONYLUREA;

BOLUS INJECTION; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; CONTINUOUS INFUSION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG OVERDOSE; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REBOUND; SHORT SURVEY;

ADOLESCENT; ADULT; AGED; DRUG THERAPY, COMBINATION; GASTROINTESTINAL AGENTS; GLUCOSE; HUMANS; HYPOGLYCEMIA; MIDDLE AGED; OCTREOTIDE; OVERDOSE; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 34547607571     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.051326     Document Type: Short Survey

References (2)

1. Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. JI Clin Endcrinol Metab 1993;76:752-6.
2. McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med 2000; 36:133-8.